Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Deadly Denials
    • Dead Zone
    • Opioid Settlement Tracking
    • Eleven Minutes
    • Broken Rehab
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Sep 8 2011

Global Fund Facility Offering Subsidized Malaria Drugs 'Could Do More Harm Than Good'

In this article in The American, a journal of the American Enterprise Institute for Public Policy Research, Roger Bate, the Legatum Fellow at the American Enterprise Institute, and Richard Tren, director of Africa Fighting Malaria, write that the Global Fund to Fight AIDS, Tuberculosis, and Malaria "launched a $225 million facility that offers subsidized malaria drugs ...provid[ing] subsidies so that shops can sell relatively expensive drugs at low cost, thereby using the reach and power of markets to save lives," they write, adding that the mechanism "is perverting the market for malaria drugs and could do more harm than good." The authors call on Congress to examine the subsidy system, writing, "The United States is not funding the subsidy, but the subsidy is harming programs the United States is supporting. Understanding and then stopping wasteful spending decisions would save money and lives" (9/8).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, July 13
  • Friday, July 10
  • Thursday, July 9
  • Wednesday, July 8
  • Tuesday, July 7
  • Monday, July 6
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF